↗2 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$8.3MSold on the market
1Companies
Oct 2, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 202616:10 | Sep 30, 2026 | PTGXProtagonist Therapeutics, Inc | Chief Financial Officer | S · Sell10b5-1 | $141.78 | −58,629 | 59,003 | -50% | −$8.3M | ||
| Oct 2, 202616:10 | Sep 30, 2026 | PTGXProtagonist Therapeutics, Inc | Chief Financial Officer | M · Exercise10b5-1 | $23.72 | +58,629 | 117,632 | +99% | $1.4M |